Researchers have found that an injection given during some asthma and Chronic Obstructive Pulmonary Disease (COPD) attacks reduces the need for further treatment by 30 per cent, which is more ...
Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...
Pharmac has announced that, from January 1 2025, it will fund palivizumab - a medicine that prevents serious illness from respiratory syncytial virus (RSV) in high-risk babies and young children - as ...
"We have been seeing an uptick in respiratory viruses, including the flu," said Elora Jiskra, a nurse practitioner with the ...
RSV season is beginning, but for the first time, parents can access an effective treatment to protect their infants from this common but dangerous virus.
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today released financial results for the second fiscal quarter ended October 31, 2024. The Company ...